Addressing racial/ethnic disparities in cancer clinical trials: Everyone has a role to play
Dany Habr, Roxanne Ferdinand
Abstract
Cancer disproportionately impacts racial/ethnic minority groups, yet they remain underrepresented in cancer clinical trials. This commentary highlights strategies for consideration by the pharmaceutical industry to ensure diversity in therapeutic clinical trials that reflects known incidence and burden of cancer and allows appropriate interpretation of risk/benefit with emerging therapies.
Topics & Concepts
MedicineEthnic groupClinical trialCancerCancer incidenceDiversity (politics)Health equityGerontologyPathologyPublic healthInternal medicineSociologyAnthropologyEthics in Clinical ResearchCancer Genomics and DiagnosticsBiomedical Ethics and Regulation